Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

PALI US Equity

Palisade Bio, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1357459 · FY ends Dec 31
$2.16
+0.12 (+5.88%)
USD · as of 2026-08-19 · marketstack
1 8-K filing · 0 13D · 3 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Commodore Capital LPsec.gov ↗
2026-08-1313G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Soleus Capital Master Fund, L.P.sec.gov ↗
2026-08-108-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-2913GSchedule 13G filed — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-29

Every row is a filed document, checked against its EDGAR index.